PERSPECTA

News from every angle

← Back to headlines

CytomX Therapeutics Prices $250M Public Offering at $5.30 Per Share

CytomX Therapeutics has priced its public offering of $250 million worth of shares at $5.30 per share.

18 Mar, 05:39 — 18 Mar, 05:39
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1h ago

CytomX Therapeutics prices $250M public offering at $5.30 per share

Read full article →

Related Stories

Stock Market: Interest in the Optima-Euroxx 'marriage' and the Fed's decisions

22m ago

SAB Biotherapeutics Prices $85M Stock Offering, Shares Slip

40m ago

K-Shaped Consumer Credit and Ukraine Build-Out Investment

46m ago

Gold Prices Remain Stable Despite Iran War and Oil Spike

1h ago